Life Science REIT plc (
LON:LABS -
Get Free Report) shares fell 2.3% on Tuesday . The stock traded as low as GBX 39.10 and last traded at GBX 39.10. 141,018 shares changed hands during mid-day trading, a decline of 97% from the average session volume of 4,232,431 shares. The stock had previously closed at GBX 40.
Life Science REIT Price Performance
The stock has a market cap of £136.85 million, a PE ratio of -4.44 and a beta of 0.08. The firm's 50 day moving average price is GBX 41.04 and its two-hundred day moving average price is GBX 39.05.
Life Science REIT Company Profile
(
Get Free Report)
Life Science REIT plc (the Company) is a closed-ended Real Estate Investment Trust (REIT) incorporated in England and Wales on 27 July 2021. The Company began trading on 19 November 2021 and its shares are admitted to trading on the Premium Listing Segment of the Main Market of the London Stock Exchange. The registered office of the Company is located at 6th Floor, 65 Gresham Street, London, EC2V 7NQ.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Life Science REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Life Science REIT wasn't on the list.
While Life Science REIT currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
